|
|
||||||||||||||
|
|
|||||||||||||||
TREATMENT |
| The first 150 words of the full text of this article appear below. |
J Ebbert
Dr J Ebbert, Mayo Clinic, Rochester, MN, USA; ebbert.jon@mayo.edu
QUESTION
Do behavioural and pharmacological interventions promote tobacco cessation in users of smokeless tobacco?
REVIEW SCOPE
Studies selected compared a behavioural or pharmacological intervention with a control intervention (usual care, placebo, or a less intensive intervention) or a different intervention for promoting tobacco abstinence in adolescent or adult users of smokeless tobacco (tobacco placed in the mouth and not burned, including moist snuff, chewing tobacco, and betel quid). Outcomes were tobacco abstinence
6 months after the intervention began. Preferred outcomes were total tobacco abstinence (rather than abstinence from smokeless tobacco alone), biochemical validation (rather than self-reported abstinence), and continuous abstinence (rather than point prevalence) at longest follow-up.
REVIEW METHODS
Cochrane Tobacco Addiction Group specialised register, Cochrane Central Register of Controlled Trials, Medline, CINAHL, EMBASE/Excerpta Medica, PsycINFO, Web of Science, Dissertation Abstracts Online, and Scopus (to Mar 2007); Healthstar, Educational Resources Information Center, National Technical
Rachel Regan Boersma
Fitchburg State College, Fitchburg, Massachusetts, USA
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |